摘要
目的对肝硬化消化道出血患者采用内科治疗的效果进行研究。方法按治疗方法的差异将患者分两组。对照组(30例)行常规治疗联合奥曲肽治疗,实验组(29例)患者在对照组治疗基础上加用艾索美拉唑、凝血酶治疗。结果对照组不良反应发生率为23.33%,实验组不良反应发生率为6.89%(P<0.05)。结论对肝硬化上消化道出血患者在常规治疗基础上行奥曲肽联合艾索美拉唑、凝血酶治疗,可有效控制患者出血症状。
Objective To study the effect of internal medicine treatment for patients with hemorrhage of digestive tract in liver cirrhosis. Methods Acording to the difference of treatment methods,the patients were divided into 2 groups. The control group(30 cases)received routine treatment combined with octreotide treatment,the experimental group(29 cases)of patients in the control group treated with esomeprazole and thrombin in the treatment of aids. Results The incidence of adverse reactions in the control group was 23.33%,and the incidence of adverse reactions in the experimental group was 6.89%(P<0.05). Conclusion Patients with cirrhosis of upper gastrointestinal bleeding in the conventional treatment based on octreotide combined with esomeprazole,thrombin therapy,can effectively control the bleeding symptoms.
出处
《大医生》
2017年第10期110-110,125,共2页
Doctor
关键词
肝硬化
上消化道出血
内科治疗
策略
liver cirrhosis
upper gastrointestinal bleeding
medical treatment
strategy
